ca-mccqe1 MCQ (SBA): Dyslipidaemia in secondary prevention

Instant feedback + full explanation. One question, done properly.

MediumCardiologyDyslipidaemia in secondary preventionca-mccqe1ca-ccfpca-rcpsc-im

A 58-year-old man with a prior NSTEMI and PCI presents for follow-up. His LDL-C is 2.3 mmol/L on high-intensity atorvastatin 80 mg daily. According to 2021 CCS dyslipidaemia guidelines, what is the most appropriate next step?

Educational content. Not a substitute for clinical judgement or local policy.

ca-mccqe1 MCQ: Dyslipidaemia in secondary prevention — Answer & Explan